The Value Equation in Upper GI: When NOT to Scope
The day opens on demand, because the largest source of waste in upper GI endoscopy is the procedure that should never have been booked. Restraint, argued properly, improves rather than compromises care — and the scope that never happens is also the greenest procedure in the building: no reprocessing cycle, no single-use kit, no patient journey.
Running order (indicative)
- Head
- Dr Roland Valorianchors the studio throughout
- Talk 1
- Dr Roland ValoriNo Scope Under 50? Missed Cancers, Headlines and the Price of Reassurance
- Talk 2
- Dr Massimiliano di PietroThe Cytosponge Debate — A Sponge on a String: The UK Case for Scope-Free Triage
- Talk 3
- Prof Raf BisschopsThe Cytosponge Debate — The European Reply: Why Hasn't the Continent Bitten?
- Live case
- Prof David TateDr Lynn DebelsCase - gastroscopy repeat on LA grade B oesophagitis without symptoms and bleeding
- Discussion
- Allremaining session time
The session, as written
Chair's framing — No scope under 50? Missed cancers, headlines and the price of reassurance. (Valori, 5 minutes). England edges towards no OGD under 50 without alarm features. What is the real miss rate, what would scoping everyone cost, and who assumes the collateral risk? Because someone must: a well-run service holds population risk deliberately — a genuinely novel idea against "do no harm" — and it must be ready for the Daily Mail's 42-year-old who saw the GP five times, was rightly not scoped, and had cancer. Named, not feared.
The Cytosponge debate. A structured two-position debate with the room voting before and after — including the honest baseline question, had you even heard of it? The UK case (di Pietro): capsule-sponge triage gives the reassurance-seeking patient "something done" without a scope, and demonstrably cuts low-value OGDs — the implementation data and the National Endoscopy Database audit. The European reply (Bisschops): if it works, why hasn't the continent bitten — insufficient evidence, or inertia dressed as caution? The post-vote shows who moved the room.
Live case — the referral the system approved. A real pending referral, scoped live: reassessment of reflux, LA grade A/B oesophagitis, booked — with everyone's blessing — on an anaesthetic list. The audience votes book, don't book, or triage before watching, then judges what the examination adds. Or fails to add. One case, and the whole value equation of a healthcare system in the room.
